Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02486263 · ClinicalTrials.gov registry record · NA
Neonatal Gastro-Esophageal Reflux Disease (GERD) Management Trial
A NA study, sponsored by Sudarshan Jadcherla.
- Completed
- Registry status
- NA
- Development phase
- 76
- Enrollment target
NCT02486263 is a NA study that has completed, run by Sudarshan Jadcherla. The registered enrollment target is 76 participants.
The verdict
NCT02486263, a NA study, has completed, sponsored by Sudarshan Jadcherla.
- COMPLETED
- Registry status
- NA
- Development phase
- 76 participants
- Enrollment target
Study Summary
The overall purpose of the investigator's study is to evaluate the causes of and treatment for feeding difficulty in infants with Gastro-esophageal Reflux Disease (GERD). New treatments can be possible only if the cause is known. Many infants have GERD and feeding difficulties, such as sucking and swallowing problems, vomiting, or delayed emptying of the stomach. Some of these infants have difficulty in protecting their airway during feeding or during reflux, and as a result can breathe fluid into their lungs or hold their breath. Most GERD treatments are done based on experience, but there is no scientific proof that these methods work for infants. GERD and feeding difficulties can lead to longer hospitalization and more stress for the family. In this clinical trial, the investigators are developing new methods to help with diagnosis as well as defining better treatment strategies in relieving GERD and GERD complications.
Interventions
- OTHER Study Arm - acid suppression plus feeding bundle
- OTHER Conventional arm - acid suppression only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2012-12 |
| Est. Completion | 2020-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02486263
The ClinicalTrials.gov registry entry for NCT02486263 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sudarshan Jadcherla, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Study Arm - acid suppression plus feeding bundle is the first listed.
NCT02486263 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02486263 about?
NCT02486263 is a clinical study titled "Neonatal Gastro-Esophageal Reflux Disease (GERD) Management Trial". The overall purpose of the investigator's study is to evaluate the causes of and treatment for feeding difficulty in infants with Gastro-esophageal Reflux Disease (GERD). New treatments can be possible only if the cause is known. Many infants have GERD and feeding difficulties, such as sucking and s...
What is the current status of trial NCT02486263?
This trial is currently completed. It is a NA study. The enrollment target is 76 participants. The study started on 2012-12. Estimated completion is 2020-03-31.
What interventions are being tested in trial NCT02486263?
The interventions under investigation include: Study Arm - acid suppression plus feeding bundle (OTHER), Conventional arm - acid suppression only (OTHER).
Who is sponsoring clinical trial NCT02486263?
This trial is sponsored by Sudarshan Jadcherla, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.